Donaldson Company Acquires Purilogics

June 14, 2022

Donaldson Company, Inc. (NYSE: DCI) has acquired Purilogics, LLC, an early-stage biotechnology developer of membrane chromatography products, for an initial purchase price of approximately $20 million plus milestone-based earnouts. The acquisition brings Purilogics' membrane purification technology into Donaldson's Industrial Filtration Solutions business to accelerate commercialization and expand Donaldson's life sciences capabilities.

Buyers
Donaldson Company, Inc.
Targets
Purilogics, LLC
Industry
Biotechnology
Location
South Carolina, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.